Stephane Ferretti

Stephane Ferretti

UNVERIFIED PROFILE

Are you Stephane Ferretti?   Register this Author

Register author
Stephane Ferretti

Stephane Ferretti

Publications by authors named "Stephane Ferretti"

Are you Stephane Ferretti?   Register this Author

21Publications

896Reads

45Profile Views

Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.

Proc Natl Acad Sci U S A 2019 01 31;116(3):1027-1032. Epub 2018 Dec 31.

Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1818798116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338866PMC
January 2019

Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.

Mol Cancer Ther 2014 May 7;13(5):1117-29. Epub 2014 Mar 7.

Authors' Affiliations: Novartis Institutes for BioMedical Research, Disease Area Oncology; Novartis Institutes for BioMedical Research, Global Discovery Chemistry; Novartis Institutes for BioMedical Research, Center for Proteomic Chemistry; Novartis Pharma AG, Oncology Translational Medicine, Basel, Switzerland; Novartis Pharma AG, Oncology Translational Medicine; Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Cambridge, Massachusetts; and Novartis Institutes for BioMedical Research, Developmental and Molecular Pathways, Shangai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-0865DOI Listing
May 2014

M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth.

Proc Natl Acad Sci U S A 2013 Jan 24;110(2):489-94. Epub 2012 Dec 24.

Disease Area Oncology, Novartis Institutes for BioMedical Research, 4056 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1212780110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545759PMC
January 2013

Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics.

Neoplasia 2009 Sep;11(9):874-81

Oncology Research, Novartis Institute of Biomedical Research, 4002 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735799PMC
http://dx.doi.org/10.1593/neo.09554DOI Listing
September 2009

Effect of adenosine A2A receptor activation in murine models of respiratory disorders.

Am J Physiol Lung Cell Mol Physiol 2006 May 9;290(5):L1036-43. Epub 2005 Dec 9.

Respiratory Diseases Area, Novartis Institutes for BioMedical Research, Horsham, England, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajplung.00422.2005DOI Listing
May 2006

Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cells.

Naunyn Schmiedebergs Arch Pharmacol 2003 Jul 18;368(1):10-6. Epub 2003 Jun 18.

Novartis Respiratory Research Centre, Wimblehurst Road, Horsham, RH12 5AB, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00210-003-0765-9
Publisher Site
http://dx.doi.org/10.1007/s00210-003-0765-9DOI Listing
July 2003